Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Terranet updates the market on its shareholding in holoride

BLINC BRegulatory press release22.04.2024 klo 09.45

Terranet AB (publ) today announces that the company does not intend to further invest in holoride GmbH at this time. The decision not to contribute with more capital reflects Terranet's strategy to prioritize and accelerate its own development of BlincVision.

Terranet invested in holoride in 2021 together with an investment consortium consisting of major industry players. Terranet's holding amounts to approx. 10%. The purpose of the investment was to take advantage of holoride's network and and identify future product synergies based on real-time vehicle data. Since the investment, Terranet has built up a large established network of contacts in the automotive industry.

Holoride has been involved in advanced discussions with new financiers about investing in the company. These discussions have, however, prolonged and existing shareholders have decided not to contribute additional capital pending the eventual completion of such a deal. As holoride's liquidity is not yet secured in the long term, the company's management has, due to German law, decided to initiate a so-called preliminary insolvency procedure (vorläufiges Insolvenzverfahren) to find new owners or investors for the company or business and, if that does not succeed, liquidate the company through bankruptcy. Terranet will be affected in terms of accounting through impairment of the value of the company's holding in holoride. Terranet's liquidity is not affected.

Nils Wollny, CEO of holoride, will remain as a board member of Terranet AB, where he will continue to contribute with his expertise in the technology and automotive industries.

"Terranet's core business is our anti-collision solution BlincVision. Our product development is progressing in accordance with our previously communicated roadmap. We look forward to the upcoming in-car prototype tests that will take place during this quarter and to return to the market with results from this prototype demo. holoride's situation will not affect Terranet's operations or liquidity.", says Magnus Andersson, CEO.

Financial Calendar Update

As a consequence of the situation in holoride, Terranet may need to make updates in the company's annual report for 2023. The new publication date for the Annual Report will therefore be April 30, instead of April 24 as previously planned.

This information is such that Terranet AB is required to make public in accordance with the EU’s Market Abuse Regulation (MAR). The information was made public by the Company’s contact person below on 22 April 2024, at 08.45 CET.

For more information, please contact:
Magnus Andersson CEO
Email: magnus.andersson@terranet.se

About Terranet AB (publ)
Terranet is on a mission to save lives in urban traffic. We develop breakthrough tech solutions for Advanced Driver Assistance Systems (ADAS) and Autonomous Vehicles (AV) that protect vulnerable road users. With a unique and patented vision technology, Terranet’s anti-collision system BlincVision scans and detects road objects multiple times faster and with higher accuracy than any other ADAS technology available today.

Terranet is based in Lund and Gothenburg, Sweden, and in the heart of the European automotive industry in Stuttgart, Germany. The company is listed on Nasdaq First North Premier Growth Market since 2017(Nasdaq: TERRNT-B).

Follow our journey at www.terranet.se

Certified Adviser to Terranet is Mangold Fondkommission AB, 08-503 015 50, ca@mangold.se.

 

Attachment

  • PM_holoride_ENG